OPKO Health Inc (NASDAQ:OPK)

2.99
Delayed Data
As of 9:10am ET
 -0.02 / -0.66%
Today’s Change
2.66
Today|||52-Week Range
7.90
-38.98%
Year-to-Date
Weekly CEO Buys Highlight
Apr 23 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close3.01
Today’s open3.00
Day’s range2.99 - 3.01
Volume1,100
Average volume (3 months)4,609,038
Market cap$2.0B
Data as of 9:10am ET, 04/24/2018

Growth & Valuation

Earnings growth (last year)-1,000.00%
Earnings growth (this year)-71.88%
Earnings growth (next 5 years)+52.05%
Revenue growth (last year)-12.62%
P/E ratioNM
Price/Sales2.57
Price/Book1.07

Competitors

 Today’s
change
Today’s
% change
PTLAPortola Pharmaceutic...+1.39+4.18%
CLVSClovis Oncology Inc-1.81-3.61%
PBYIPuma Biotechnology I...+0.55+0.90%
MNKMallinckrodt Plc-0.69-5.01%
Data as of 4:00pm ET, 04/23/2018

Financials

Next reporting dateMay 9, 2018
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$1.1B
Annual profit (last year)-$308.9M
Net profit margin-28.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
Chief Financial Officer &
Senior Vice President
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts